Literature DB >> 22277012

Validation of a formula for predicting daily CD34(+) cell collection by leukapheresis.

Eric R Rosenbaum1, Bernadette O'Connell, Michele Cottler-Fox.   

Abstract

BACKGROUND AIMS: The ability to predict how many CD34(+) cells a donor will collect on a given day is vital for efficient leukapheresis.
METHODS: We validated a formula to predict daily CD34(+) cell collections by leukapheresis, calculated as follows: (peripheral blood CD34(+) cells/L) × (adjusted collection efficiency of 30%)/body weight (kg), multiplied by the number of liters processed. This validation was performed from 234 donors undergoing 30 L large volume leukapheresis (LVL) and 162 donors undergoing smaller collections (non-LVL). The LVL group consisted of 811 collection events (625 multiple myeloma, 186 non-myeloma). The non-LVL group consisted of 224 collection events (196 multiple myeloma, 28 non-myeloma). All predicted and observed CD34(+) cell collection numbers were plotted (predicted versus observed) and assessed using linear regression analyses. Linear correlation coefficients (r-values), slopes and intercepts of the regression lines were evaluated.
RESULTS: Predicted versus observed data points across all quantities of CD34(+) cells/kg collected by both LVL and non-LVL had strong r-values of 0.947 and 0.913, respectively, demonstrating near perfect positive linear correlations. Data for LVL collections subgrouped by number of cells collected (poor, intermediate and good), mobilization regimen, collection day and diagnosis were analyzed the same way and showed consistent findings.
CONCLUSIONS: We have validated a formula with a strong ability to predict collection of CD34(+) cells/kg that would allow for individualization of collection for any donor once the peripheral blood CD34(+) cell count and optimal goal of collection were known; to date this has not been published by other groups.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22277012     DOI: 10.3109/14653249.2011.652733

Source DB:  PubMed          Journal:  Cytotherapy        ISSN: 1465-3249            Impact factor:   5.414


  8 in total

1.  Successful hematopoietic stem cell mobilization and apheresis collection using plerixafor alone in sickle cell patients.

Authors:  Erica B Esrick; John P Manis; Heather Daley; Cristina Baricordi; Hélène Trébéden-Negre; Francis J Pierciey; Myriam Armant; Sarah Nikiforow; Matthew M Heeney; Wendy B London; Luca Biasco; Mohammed Asmal; David A Williams; Alessandra Biffi
Journal:  Blood Adv       Date:  2018-10-09

2.  Hematopoietic progenitor cell collection after autologous transplant for multiple myeloma: low platelet count predicts for poor collection and sole use of resulting graft enhances risk of myelodysplasia.

Authors:  X Papanikolaou; E R Rosenbaum; L N Tyler; J Sawyer; C J Heuck; B Barlogie; M Cottler-Fox
Journal:  Leukemia       Date:  2013-07-15       Impact factor: 11.528

3.  An intra-patient comparison of blood cell separators Spectra and Optia in patients and donors undergoing blood mononuclear cell collections at a single institution for subsequent autologous or allogeneic hematopoietic cell transplantation reveals comparable collection efficiencies.

Authors:  A Drezet; A Granata; C Lemarie; B Calmels; C Chabannon
Journal:  Bone Marrow Transplant       Date:  2016-03-07       Impact factor: 5.483

4.  Analysis of CD34+ cell collection using two mobilization regimens for newly diagnosed multiple myeloma patients reveals the separate impact of mobilization and collection variables.

Authors:  Ahmed Abuabdou; Eric R Rosenbaum; Saad Zafar Usmani; Bart Barlogie; Michele Cottler-Fox
Journal:  J Clin Apher       Date:  2013-12-18       Impact factor: 2.821

5.  Platelet Count before Peripheral Blood Stem Cell Mobilization Is Associated with the Need for Plerixafor But Not with the Collection Result.

Authors:  Marc-Andrea Baertsch; Katharina Kriegsmann; Petra Pavel; Thomas Bruckner; Michael Hundemer; Mark Kriegsmann; Anthony D Ho; Hartmut Goldschmidt; Patrick Wuchter
Journal:  Transfus Med Hemother       Date:  2017-10-04       Impact factor: 3.747

6.  A simplified CD34+ based preharvest prediction tool for HPC(A) collection.

Authors:  Reuben P Jacob; Scott T Avecilla; Eileen M Walsh; Peter G Maslak; Sergio A Giralt
Journal:  Transfusion       Date:  2021-03-11       Impact factor: 3.337

7.  Effect of high-dose plerixafor on CD34+ cell mobilization in healthy stem cell donors: results of a randomized crossover trial.

Authors:  Jeremy Pantin; Enkhtsetseg Purev; Xin Tian; Lisa Cook; Theresa Donohue-Jerussi; Elena Cho; Robert Reger; Matthew Hsieh; Hanh Khuu; Gary Calandra; Nancy L Geller; Richard W Childs
Journal:  Haematologica       Date:  2016-10-20       Impact factor: 9.941

8.  Algorithms utilizing peripheral blood hematopoietic progenitor cell counts in lieu of some CD34+ cell counts predict successful peripheral blood stem cell collections with substantial time and cost savings.

Authors:  B W Steussy; M Capper; M D Krasowski; N S Rosenthal; A J Schlueter
Journal:  ISBT Sci Ser       Date:  2016-10-05
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.